2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 1.019 | 946 | 1.124 | 78 | 287 | 0 | 0 | 58 | 0 | 0 |
Total Income - EUR | 1.019 | 946 | 1.124 | 78 | 287 | 0 | 0 | 58 | 0 | 0 |
Total Expenses - EUR | 1.003 | 799 | 942 | 65 | 446 | 0 | 0 | 50 | 0 | 0 |
Gross Profit/Loss - EUR | 16 | 146 | 182 | 13 | -160 | 0 | 0 | 8 | 0 | 0 |
Net Profit/Loss - EUR | -14 | 118 | 148 | 10 | -168 | 0 | 0 | 8 | 0 | 0 |
Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Tricovid Srl
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 1.135 | 1.123 | 1.104 | 1.084 | 1.063 | 1.043 | 1.020 | 1.023 | 1.020 | 5.044 |
Current Assets | 6.495 | 6.548 | 6.622 | 6.480 | 5.141 | 5.041 | 4.932 | 4.956 | 4.679 | 23.144 |
Inventories | 6.053 | 5.585 | 4.944 | 4.952 | 4.736 | 4.646 | 4.543 | 4.508 | 4.232 | 20.935 |
Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 443 | 963 | 1.678 | 1.528 | 405 | 395 | 389 | 448 | 447 | 2.209 |
Shareholders Funds | -3.930 | -3.773 | -3.561 | -3.485 | -3.585 | -3.517 | -3.439 | -3.442 | -3.694 | -18.274 |
Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 200 |
Debts | 11.561 | 11.444 | 11.287 | 11.048 | 9.789 | 9.601 | 9.391 | 9.421 | 9.393 | 46.462 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 1 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
Main CAEN | "1320 - 1320" | |||||||||
CAEN Financial Year |
4711
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Tricovid Srl